Bayer Genuine Aspirin
- Product NDC
- 70264-013
- Requested package NDC
- 70264-013-01
- 11-digit product format
- 702640013
- Labeler code
- 70264
- Product ID
- 70264-013_43cb3193-0671-d065-e063-6394a90afd47
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Aspirin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- R J General Corporation
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2014-07-31
- Substance
- ASPIRIN
- Active strength
- 325 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2022-08-30 03:57 UTC · source 2022-08-29 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | 9bebd1f3094a… | 5416666fcb17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bayer Genuine Aspirin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ASPIRIN | 325 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| R16CO5Y76E | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 23daa359-d40f-4f64-81be-6d154f41df9f | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d7724692-1155-4cc8-a415-22f5fc4aec35 | Product name | 6 | 20220216 |
| bde672ba-4805-28d0-1986-73543d41b412 | Product name | 2 | 20210201 |
| f212291f-05fe-9603-fc7e-bd73e38ce1e6 | Product name | 2 | 20161129 |
| ade821ba-260a-47e2-bd89-743e27ac9906 | Product name | 1 | 20161121 |
| 182f9ab4-4ab5-c449-200f-87ce2ce8e550 | Product name | 2 | 20151105 |
| 9425d234-4ae1-4b53-adc6-8cc7af6dd657 | Product name | 1 | 20150929 |
| 2a21311a-89e2-0e83-2ebd-117f9798b2b2 | Product name | 1 | 20140508 |
| 9007e8a7-ff50-f9b9-7945-f2a1deadd94e | Product name | 1 | 20140508 |
| 96c2be53-8e44-452d-56a2-d255b2f1af2d | Product name | 1 | 20140508 |
| bf8bd5f7-495f-4022-2780-7ded7ea7ea44 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70264-013-01 | 2022-12-26 | C162847 | 48780-1 | 9d75b9d0-baa9-f424-e053-dadaa90a57ce | Bayer Genuine Aspirin ® |
| 70264-013-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-baa9-f424-e053-dadaa90a57ce | Bayer Genuine Aspirin ® |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70264-013-01 | Bayer Genuine Aspirin | 50 in 1 CARTON | TABLET | 50 | 6 | |
| 70264-013-01 | Bayer Genuine Aspirin | 2 in 1 POUCH | TABLET | 2 | 6 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dolex Children Pain and Fever | ACETAMINOPHEN | Pharmadel LLC | f9158463-aeb1-5de0-e053-6294a90a748b | 2024-03-04 | Warnings | M013 |
| SEDALMEX FORTE | ACETAMINOPHEN, ASPIRIN, CAFFEINE | Belmora LLC | 33b3508e-4caa-4d05-9b15-cb82a2ee2d4d | 2024-02-28 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | AMERISOURCE BERGEN | 2b923a97-836c-4dac-a8c0-3047a35fb62e | 2024-02-23 | Warnings | M013 |
| Pain Reliever PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | BJWC (Berkley & Jensen / BJ's) | b20a08f3-c9c0-4bd9-8ce0-acb932b5bb86 | 2024-02-22 | Warnings | M013 |
| M-PAP | ACETAMINOPHEN | Bryant Ranch Prepack | 31a41976-7f65-42d7-acf5-de9c2c5ca58e | 2024-02-20 | Warnings | M013 |
| Publix Fast Relief Effervescent - Original Flavor | ASPIRIN | PUBLIX SUPER MARKETS INC. | 0a342f72-45fd-3e12-e063-6394a90ae33e | 2024-02-16 | Warnings | M013 |
| Equaline Effervescent Pain Reliever | ASPIRIN | UNITED NATURAL FOODS, INC. DBA UNFI | 0761299a-e913-7665-e063-6394a90a6003 | 2024-02-16 | Warnings | M013 |
| TopCare Effervescent Pain Relief | ASPIRIN | TOPCO ASSOCIATES LLC | 075f36e1-110c-e839-e063-6294a90a89d7 | 2024-02-16 | Warnings | M013 |
| Extra Strength Pain Reliever | ACETAMINOPHEN | INGLES MARKETS, INC. | 115d0b4f-6f0f-79a9-e063-6394a90ab18a | 2024-02-14 | Warnings | M013 |
| PANADOL | ACETAMINOPHEN | Haleon US Holdings LLC | e1799765-c247-42b4-ad6a-8ba7d136abf2 | 2024-02-06 | Warnings | M013 |
| Panadol Cold and Flu NonDrowsy | ACETAMINOPHEN AND PHENYLEPRINE HCL | Haleon US Holdings LLC | f626ab17-01c9-4493-ba9e-0c8c11146384 | 2024-02-06 | Warnings | M013 |
| PANADOL Extra | ACETAMINOPHEN AND CAFFEINE | Haleon US Holdings LLC | e5c2d88a-d903-4ca0-b895-f27e791dfc4e | 2024-02-06 | Warnings | M013 |
| PANADOL Extra Strength | ACETAMINOPHEN | Haleon US Holdings LLC | b2fe7f47-1a2e-40ee-8f8f-38f2028dce1b | 2024-02-06 | Warnings | M013 |
| PANADOL Extra Strength | ACETAMINOPHEN | Haleon US Holdings LLC | 9d384e88-5c11-4600-ac6c-a38371570138 | 2024-02-06 | Warnings | M013 |
| PANADOL | ACETAMINOPHEN | Haleon US Holdings LLC | 95801755-db54-4ad7-bec1-52671914f6ca | 2024-02-06 | Warnings | M013 |
| PANADOL PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | Haleon US Holdings LLC | 01e7dddb-755c-4745-b701-edcdb6209064 | 2024-02-06 | Warnings, Adverse reactions | M013 |
| PANADOL PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HCL | Haleon US Holdings LLC | fe7cd1f2-9b00-4ded-99c2-8a152c71093c | 2024-02-06 | Warnings, Adverse reactions | M013 |
| Childrens Pain and Fever | ACETAMINOPHEN | AptaPharma Inc. | 9064943f-836f-4853-b6f2-2c4879941eeb | 2024-02-02 | Warnings | M013 |
| Quality Choice Effervescent Pain Relief | ASPIRIN | CHAIN DRUG MARKETING ASSOCIATION, INC. | 079af5d7-1be8-2a93-e063-6294a90a496d | 2024-02-01 | Warnings | M013 |
| MEDI-FIRST Non-Aspirin | ACETAMINOPHEN | Proficient Rx LP | 4c84948d-3a95-4c53-8529-7e7b9d8bb6df | 2024-02-01 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 212033 | aspirin 325 MG Oral Tablet | PSN | 23daa359-d40f-4f64-81be-6d154f41df9f | 6 |
| 211874 | BAYER Aspirin 325 MG Oral Tablet | PSN | 23daa359-d40f-4f64-81be-6d154f41df9f | 6 |
| 211874 | aspirin 325 MG Oral Tablet [Bayer Aspirin] | SBD | 23daa359-d40f-4f64-81be-6d154f41df9f | 6 |
| 212033 | aspirin 325 MG Oral Tablet | SCD | 23daa359-d40f-4f64-81be-6d154f41df9f | 6 |
| 212033 | ASA 325 MG Oral Tablet | SY | 23daa359-d40f-4f64-81be-6d154f41df9f | 6 |
| 211874 | ASA 325 MG Oral Tablet [Bayer Aspirin] | SY | 23daa359-d40f-4f64-81be-6d154f41df9f | 6 |
| 211874 | Bayer Aspirin 325 MG Oral Tablet | SY | 23daa359-d40f-4f64-81be-6d154f41df9f | 6 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70264-013-01 | 70264001301 | 50 POUCH in 1 CARTON (70264-013-01) / 2 TABLET in 1 POUCH | 50 pouch | 2014-07-31 | 0000-00-00 | No | No | Current |